We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$33.4B
AUM Growth
+$3.13B
Cap. Flow
+$152M
Cap. Flow %
0.46%
Top 10 Hldgs %
43.52%
Holding
342
New
32
Increased
128
Reduced
72
Closed
5

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$143M
2
NFLX icon
Netflix
NFLX
+$108M
3
JPM icon
JPMorgan Chase
JPM
+$78.3M
4
TTE icon
TotalEnergies
TTE
+$29.9M
5
PG icon
Procter & Gamble
PG
+$22.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$37.1M
2
ASML icon
ASML
ASML
+$31.8M
3
AAPL icon
Apple
AAPL
+$30.8M
4
SPGI icon
S&P Global
SPGI
+$24.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$23.9M

Sector Composition

Rank Sector Weight
1 Technology 24.18%
2 Financials 19.66%
3 Consumer Staples 17.51%
4 Communication Services 10.31%
5 Healthcare 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
176
MetLife
MET
$61.7B
$1.51M ﹤0.01%
24,168
+13,074
+118% +$821K
FISV
177
Fiserv Inc
FISV
$27.1B
$1.5M ﹤0.01%
14,444
-1,200
-8% -$124K
APH icon
178
Amphenol
APH
$194B
$1.49M ﹤0.01%
68,272
AIG icon
179
American International
AIG
$39.4B
$1.46M ﹤0.01%
25,659
+11,740
+84% +$669K
CADE
180
DELISTED
Cadence Bank
CADE
$1.44M ﹤0.01%
48,235
+6,435
+15% +$194K
GPC icon
181
Genuine Parts
GPC
$18.4B
$1.44M ﹤0.01%
10,253
+6,433
+168% +$851K
BMY icon
182
Bristol-Myers Squibb
BMY
$131B
$1.43M ﹤0.01%
22,977
+4,882
+27% +$286K
GD icon
183
General Dynamics
GD
$96.5B
$1.41M ﹤0.01%
6,752
+3,000
+80% +$606K
KEX icon
184
Kirby Corp
KEX
$7.31B
$1.32M ﹤0.01%
22,255
ICLR icon
185
Icon
ICLR
$13.1B
$1.31M ﹤0.01%
4,220
BAX icon
186
Baxter International
BAX
$12.3B
$1.3M ﹤0.01%
15,144
TSM icon
187
TSMC
TSM
$2.17T
$1.29M ﹤0.01%
10,717
+500
+5% +$58.6K
CNQ icon
188
Canadian Natural Resources
CNQ
$104B
$1.28M ﹤0.01%
61,942
IFF icon
189
International Flavors & Fragrances
IFF
$21.3B
$1.27M ﹤0.01%
8,404
+2,312
+38% +$337K
GRFS
190
Grifois
GRFS
$5.14B
$1.25M ﹤0.01%
111,452
WWE
191
DELISTED
World Wrestling Entertainment
WWE
$1.24M ﹤0.01%
25,070
WM icon
192
Waste Management
WM
$87.2B
$1.23M ﹤0.01%
7,346
+1,000
+16% +$161K
DE icon
193
Deere & Co
DE
$182B
$1.22M ﹤0.01%
3,565
+69
+2% +$24K
BALL icon
194
Ball Corp
BALL
$15.9B
$1.19M ﹤0.01%
12,388
TMO icon
195
Thermo Fisher Scientific
TMO
$227B
$1.19M ﹤0.01%
1,782
+223
+14% +$139K
ROK icon
196
Rockwell Automation
ROK
$47.6B
$1.18M ﹤0.01%
3,377
CME icon
197
CME Group
CME
$101B
$1.17M ﹤0.01%
5,139
+413
+9% +$90.9K
IDXX icon
198
Idexx Laboratories
IDXX
$40.1B
$1.16M ﹤0.01%
1,754
REGN icon
199
Regeneron Pharmaceuticals
REGN
$81.7B
$1.14M ﹤0.01%
1,800
+1,300
+260% +$799K
SLF icon
200
Sun Life Financial
SLF
$44.3B
$1.13M ﹤0.01%
20,261
+9,853
+95% +$545K

Similar funds

Fayez Sarofim & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Fayez Sarofim & Co held 342 positions worth $33.4B, up 10% from $30.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co's Q4 2021 filing shows 32 new, 128 increased, 72 reduced and 5 closed positions. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 43,479 shares worth $10.5M. The largest sale was Microsoft, an estimated $37.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q4 2021 buy was Vanguard Morningstar Total Stock Market ETF: 43,479 shares worth $10.5M.
  • Fayez Sarofim & Co added most to ExxonMobil in Q4 2021, an estimated $143M increase.
  • Fayez Sarofim & Co's biggest Q4 2021 reduction was Microsoft, cutting an estimated $37.1M.
  • Fayez Sarofim & Co fully exited American National Group, Inc. Common Stock in Q4 2021, selling an estimated $14.1M.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $33.4B portfolio in Q4 2021.
  • Fayez Sarofim & Co opened 32 new positions and closed 5 in Q4 2021.
  • Fayez Sarofim & Co's portfolio value rose 10% quarter-over-quarter to $33.4B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2021, filed 11 Feb 2022.